US OptionsDetailed Quotes
PRCT250117C45000
- 28.75
- 0.000.00%
15min DelayClose Jan 17 16:00 ET
0.00High0.00Low
28.75Open28.75Pre Close0 Volume6 Open Interest45.00Strike Price0.00Turnover0.00%IV-2.99%PremiumJan 17, 2025Expiry Date31.02Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.44Leverage Ratio--Theta--Rho--Eff Leverage--Vega
PROCEPT BioRobotics Stock Discussion
Sign in to post a comment
$Fractyl Health (GUTS.US)$ $Pixie Dust Technologies(Delisted) (PXDT.US)$ $Oklo Inc (OKLO.US)$ $Revance Therapeutics (RVNC.US)$ $PROCEPT BioRobotics (PRCT.US)$ $Atlas Lithium (ATLX.US)$ $EyePoint Pharmaceuticals (EYPT.US)$ $Porch Group (PRCH.US)$ $Top Wealth Group Holding (TWG.US)$ $Global Mofy AI (GMM.US)$ $Monte Rosa Therapeutics (GLUE.US)$ $Evoke Pharma (EVOK.US)$ $Greenlane (GNLN.US)$ $Autonomix Medical (AMIX.US)$ $Healthcare Triangle (HCTI.US)$
📊⚡️📊
📊⚡️📊
11
6
The market climbed after feeling the first day of pullback in nearly two weeks the day before.
Just after 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.42%, the $Dow Jones Industrial Average (.DJI.US)$ traded +0.14%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.57%.
Investors are digesting retail earnings and the tail end of tech reports, alongside comments made during the Democratic National Committee, where the Harris campaign made public t...
Just after 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.42%, the $Dow Jones Industrial Average (.DJI.US)$ traded +0.14%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.57%.
Investors are digesting retail earnings and the tail end of tech reports, alongside comments made during the Democratic National Committee, where the Harris campaign made public t...
38
20
10
Good morning, traders. Happy Wednesday. The market is advancing again after pulling back from a nearly ten day climb Tuesday. Retail earnings this morning came in mixed, the DNC is still roaring on in Chicago.
My name is Kevin Travers; here are stories moooving on the U.S. stock market today.
Target Corporation $Target (TGT.US)$ climbed 12% Wednesday after reporting Q2 results that exceeded expectations and boosted its ful...
My name is Kevin Travers; here are stories moooving on the U.S. stock market today.
Target Corporation $Target (TGT.US)$ climbed 12% Wednesday after reporting Q2 results that exceeded expectations and boosted its ful...
48
7
6
Recent insider selling of PROCEPT BioRobotics shares and lack of insider buying, along with not particularly high insider ownership, raises caution about the company. Consider the company's investment risks before purchasing.
PROCEPT BioRobotics has a conservative balance sheet and could probably eliminate its debt without much difficulty. Despite losing money over the last twelve months, the company's solid revenue growth may indicate a path to profitability.
Insider selling at PROCEPT BioRobotics' current share price levels doesn't imply major concern nor positivity. Lack of insider purchases in the past year and shares held by insiders, combined with past sales, call for careful investments due to potential company risks.
Upgrades
• $Allogene Therapeutics (ALLO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $9)
• $ChampionX (CHX.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $22 (from $25)
• $CSX Corp (CSX.US)$ : Stifel Upgrades to Buy from Hold - PT $37 (from $39)
• $TechnipFMC (FTI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $8 (from $9.50)
• $Norfolk Southern (NSC.US)$ : Stifel Upgrades to Buy from Hold - PT $2...
• $Allogene Therapeutics (ALLO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $9)
• $ChampionX (CHX.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $22 (from $25)
• $CSX Corp (CSX.US)$ : Stifel Upgrades to Buy from Hold - PT $37 (from $39)
• $TechnipFMC (FTI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $8 (from $9.50)
• $Norfolk Southern (NSC.US)$ : Stifel Upgrades to Buy from Hold - PT $2...
14
1
4
$PROCEPT BioRobotics (PRCT.US)$ 50 today?
2
No comment yet
Tesla 1st : Agreed